WST

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: BAX JNJ BDX DHR TMO STE WAT XRAY MRK

| Held by: VTI VOO VO MOAT VUG SPY IVV RSP NOBL VOT

Index	S&P 500	P/E	37.97	EPS (ttm)	6.68	Insider Own	0.62%	Shs Outstand	71.90M	Perf Week	1.10%
Market Cap	18.23B	Forward P/E	33.64	EPS next Y	7.54	Insider Trans	0.00%	Shs Float	71.46M	Perf Month	2.96%
Enterprise Value	18.03B	PEG	4.83	EPS next Q	1.68	Inst Own	98.25%	Short Float	2.15%	Perf Quarter	12.71%
Income	487.70M	P/S	6.16	EPS this Y	0.14%	Inst Trans	0.24%	Short Ratio	2.25	Perf Half Y	13.31%
Sales	2.96B	P/B	6.22	EPS next Y	11.50%	ROA	13.11%	Short Interest	1.53M	Perf YTD	-22.61%
Book/sh	40.74	P/C	35.76	EPS next 5Y	7.86%	ROE	17.72%	52W High	352.33 -28.05%	Perf Year	-17.03%
Cash/sh	7.09	P/FCF	52.99	EPS past 3/5Y	-8.31% 15.84%	ROIC	15.17%	52W Low	187.43 35.25%	Perf 3Y	-15.16%
Dividend Est.	0.68 (0.27%)	EV/EBITDA	22.90	Sales past 3/5Y	0.72% 9.43%	Gross Margin	35.32%	Volatility	2.77% 2.15%	Perf 5Y	-3.85%
Dividend TTM	0.84 (0.33%)	EV/Sales	6.09	EPS Y/Y TTM	-5.50%	Oper. Margin	21.12%	ATR (14)	6.42	Perf 10Y	358.08%
Dividend Ex-Date	Nov 12, 2025	Quick Ratio	2.08	Sales Y/Y TTM	2.88%	Profit Margin	16.48%	RSI (14)	56.22	Recom	1.59
Dividend Gr. 3/5Y	5.42% 5.75%	Current Ratio	2.78	EPS Q/Q	20.37%	SMA20	1.97%	Beta	1.06	Target Price	314.73
Payout	12.27%	Debt/Eq	0.11	Sales Q/Q	9.15%	SMA50	5.39%	Rel Volume	1.10	Prev Close	263.74
Employees	10600	LT Debt/Eq	0.10	Earnings	Jul 24 BMO	SMA200	-0.05%	Avg Volume	681.62K	Price	253.50
IPO	Mar 17, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.92% 5.57%	Trades		Volume	746,174	Change	-3.88%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Initiated	Rothschild & Co Redburn	Buy	$311
Jun-24-25	Initiated	Barclays	Equal Weight	$245
Mar-18-25	Initiated	Evercore ISI	Outperform	$275
Feb-14-25	Upgrade	Deutsche Bank	Hold → Buy	$250
Jan-08-25	Initiated	Citigroup	Buy	$400
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-12-24	Upgrade	UBS	Neutral → Buy	$350 → $390
Feb-07-24	Upgrade	Jefferies	Hold → Buy	$323 → $536
Jun-16-23	Upgrade	BofA Securities	Neutral → Buy	$390 → $405
Apr-11-23	Upgrade	Stephens	Equal-Weight → Overweight	$330 → $400
Dec-14-22	Initiated	Deutsche Bank	Hold	$250
Nov-30-22	Initiated	UBS	Neutral	$250
Oct-28-22	Downgrade	BofA Securities	Buy → Neutral	$385 → $250
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$350
Oct-14-20	Initiated	Stephens	Equal-Weight	$300
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy	$280
Apr-24-20	Upgrade	BofA/Merrill	Underperform → Neutral	$145 → $200
Dec-12-19	Downgrade	BofA/Merrill	Neutral → Underperform
Jul-26-19	Upgrade	BofA/Merrill	Underperform → Neutral
May-01-19	Downgrade	Jefferies	Buy → Hold	$122

Show Previous Ratings

Today 07:17AM	5 Must-Buy Laggards of 2025 With Double-Digit Short-Term Price Upside (Zacks)
Sep-11-25 12:24PM	Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study (Zacks)
12:20PM	Here's Why You Should Retain OPKO Health Stock in Your Portfolio (Zacks)
08:24AM	Reasons to Add West Pharmaceutical Stock to Your Portfolio Now (Zacks)
Sep-10-25 12:35PM	Reasons to Retain Avanos Medical Stock in Your Portfolio Now (Zacks)
10:56AM	Loading…
10:56AM	Analyst Report: West Pharmaceutical Services, Inc. (Morningstar Research)
09:02AM	Dentsply Sirona Retains Wellspect Following Strategic Review (Zacks)
Sep-09-25 01:25PM	Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System (Zacks)
09:00AM	Should You Be Optimistic on West Pharmaceutical (WST)? (Insider Monkey)
08:45AM	Lifeward Achieves European Approval for Latest ReWalk Exoskeleton (Zacks)
Sep-08-25 12:36PM	Cardinal Health Expands At-Home Solutions With New Texas Facility (Zacks)
08:07AM	GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System (Zacks)
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
08:06AM	Here's Why You Should Hold Cencora Stock in Your Portfolio Now (Zacks)
Sep-04-25 11:40AM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
01:23PM	Loading…
Sep-03-25 01:23PM	HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
08:50AM	STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep (Zacks)
Sep-02-25 01:32PM	IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection (Zacks)
Sep-01-25 12:53PM	GEHC Launches AI-Powered Vivid Pioneer Cardiac Ultrasound System (Zacks)
09:51AM	FDA Identifies ICU Medical's Plum Duo Recall as Serious Type (Zacks)
Aug-29-25 12:24PM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
11:30AM	Why Is Align Technology (ALGN) Up 9.4% Since Last Earnings Report? (Zacks)
09:47AM	Here's Why You Should Add CLOV Stock to Your Portfolio Now (Zacks)
09:47AM	COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down (Zacks)
Aug-28-25 10:24AM	VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up (Zacks)
Aug-27-25 12:25PM	PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment (Zacks)
11:08AM	West Pharmaceutical Stock: Is Wall Street Bullish or Bearish? (Barchart)
08:29AM	Here's Why You Should Retain CONMED Stock in Your Portfolio for Now (Zacks)
Aug-25-25 12:52PM	Natera Shares Rise on the Launch of AI Platform for Precision Oncology (Zacks)
Aug-24-25 11:32PM	Q2 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks (StockStory)
01:30PM	Loading…
Aug-22-25 01:30PM	BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care (Zacks)
Aug-21-25 01:33PM	Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market (Zacks)
01:30PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
06:00AM	West to Participate in Upcoming Investor Conferences in September 2025 (PR Newswire)
Aug-20-25 01:24PM	Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring (Zacks)
Aug-19-25 10:13AM	NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment (Zacks)
08:50AM	Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds (Zacks)
Aug-15-25 09:55AM	Wall Street Analysts See a 28.68% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High? (Zacks)
Aug-14-25 11:17AM	Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
11:05AM	Reasons to Hold HealthEquity Stock in Your Portfolio for Now (Zacks)
Aug-13-25 02:39PM	Investors Playing More Defense Even as Stocks Climb to New Highs (Wealth Management)
12:58PM	RGTI Stock Down Despite Q2 Earnings Top Estimates, Revenues Decline Y/Y (Zacks)
Aug-12-25 01:02PM	SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts (Zacks)
11:41AM	Reasons to Add Veeva Systems Stock to Your Portfolio for Now (Zacks)
10:58AM	Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies (Zacks)
10:37AM	CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls (Zacks)
Aug-11-25 12:59PM	Encompass Health Q2 Earnings Beat Estimates, Stock Up 7.4% (Zacks)
08:28AM	4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks (Zacks)
Aug-08-25 12:11PM	Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y (Zacks)
12:07PM	PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises (Zacks)
11:51AM	DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down (Zacks)
11:47AM	AMN Stock Slips Despite Q2 Earnings & Revenue Beat, Margins Down (Zacks)
09:45AM	Solventum Stock Gains on Q2 Earnings & Revenue Beat, Margins Improve (Zacks)
Aug-07-25 11:06AM	XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up (Zacks)
11:02AM	BD Stock Gains in Pre-Market Following Q3 Earnings Beat, Margins Up (Zacks)
08:22AM	MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View (Zacks)
Aug-06-25 01:11PM	ACB Stock Down as Q1 Earnings Miss Estimates, Revenues Up Y/Y (Zacks)
01:08PM	Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down (Zacks)
01:02PM	QuidelOrtho Stock Gains Following Q2 Earnings Beat, Margins Expand (Zacks)
12:49PM	DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands (Zacks)
12:46PM	MASI Stock Slips Despite Q2 Earnings and Revenue Beat, Margins Expand (Zacks)
11:01AM	Select Medical Shares Down 20% Despite Q2 Earnings Beat (Zacks)
10:39AM	FMS Stock Rises as Q2 Earnings Beat Estimates, Revenues Gain Y/Y (Zacks)
10:39AM	CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View (Zacks)
10:28AM	COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised (Zacks)
Aug-05-25 11:40AM	HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down (Zacks)
11:38AM	INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts (Zacks)
Aug-04-25 12:06PM	AVTR Stock Declines as Q2 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
Aug-01-25 12:20PM	OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands (Zacks)
12:07PM	TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up (Zacks)
11:03AM	Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses (Zacks)
Jul-31-25 01:27PM	GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised (Zacks)
01:25PM	CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised (Zacks)
01:18PM	Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands (Zacks)
01:33AM	The 5 Most Interesting Analyst Questions From West Pharmaceutical Services's Q2 Earnings Call (StockStory)
Jul-30-25 12:51PM	GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises (Zacks)
09:55AM	Wall Street Analysts Think West Pharmaceutical (WST) Could Surge 25.26%: Read This Before Placing a Bet (Zacks)
Jul-29-25 01:02PM	Ecolab Stock Down in Pre-Market Post Q2 Earnings Miss, Margins Expand (Zacks)
11:35AM	UnitedHealth Q2 Earnings Miss Estimates on Increasing Medical Costs (Zacks)
11:30AM	Universal Health Q2 Earnings Beat on Strong Acute Care Admissions (Zacks)
Jul-28-25 12:00PM	West Pharmaceutical (WST) Upgraded to Strong Buy: Here's Why (Zacks)
10:00AM	Best Momentum Stocks to Buy for July 28th (Zacks)
Jul-26-25 05:30AM	Investing.coms stocks of the week (Investing.com)
Jul-25-25 07:02AM	West Pharmaceutical: Q2 Earnings Snapshot (Associated Press Finance) -5.59%
01:34AM	WST Q2 Deep Dive: High-Value Product Momentum Drives Guidance Increase (StockStory)
Jul-24-25 05:28PM	S&P 500 Gains and Losses Today: West Pharmaceutical Services Stock Surges; Dow, LKQ Shares Fall (Investopedia) +22.78%
04:34PM	West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings (Investor's Business Daily)
01:58PM	Analyst Report: West Pharmaceutical Services, Inc. (Morningstar Research)
12:56PM	Why Are West Pharmaceutical Services (WST) Shares Soaring Today (StockStory)
12:23PM	Top Stock Movers Now: Alphabet, Tesla, IBM, Dow, and More (Investopedia)
10:46AM	WST Stock Rises on Q2 Earnings Beat, EPS View Up on Tariff & FX Benefit (Zacks)
10:38AM	West Pharma Lifts Outlook On Surging GLP-1 Demand, Stock Soars (Benzinga)
10:15AM	West Pharmaceutical Stock On Track for Best Day Ever After Earnings (Barrons.com)
07:36AM	West Pharmaceutical Stock Surges After Earnings. GLP-1s Play a Role. (Barrons.com)
07:10AM	West Pharmaceutical Services (WST) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
06:08AM	West Pharmaceutical Services (NYSE:WST) Delivers Impressive Q2, Stock Jumps 11.1% (StockStory)
06:00AM	West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance (PR Newswire)
Jul-22-25 11:08PM	West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For (StockStory)
12:11PM	WST Q2 Earnings Preview: Will the Stock's Segmental Edge Hold Up? (Zacks)
10:08AM	Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks (Insider Monkey)

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Birkett Bernard	Sr VP, Chief Financial Officer	Feb 18 '25	Option Exercise	211.00	904	190,814	7,669	Feb 20 09:44 PM
Reiss-Clark Cindy	Chief Commercial Officer	Feb 18 '25	Option Exercise	211.00	246	51,940	5,131	Feb 20 09:16 PM
MacKay Kimberly Banks	SVP, GC & Corporate Secretary	Feb 18 '25	Option Exercise	211.00	246	51,940	1,605	Feb 20 09:13 PM
Favorite Annette F	Sr. VP & Chief HR Officer	Feb 18 '25	Option Exercise	211.00	246	51,940	6,823	Feb 20 09:11 PM
Winters Chad	VP, Chief Accounting Officer	Feb 18 '25	Option Exercise	211.00	82	17,313	1,391	Feb 20 09:09 PM
Witherspoon Charles	VP & Treasurer	Feb 18 '25	Option Exercise	211.00	66	13,864	1,319	Feb 20 09:08 PM
Green Eric Mark	President, CEO and Board Chair	Feb 18 '25	Option Exercise	211.00	2,461	519,269	170,369	Feb 20 09:06 PM
Witherspoon Charles	VP & Treasurer	Oct 29 '24	Option Exercise	173.22	478	82,799	1,956	Oct 31 12:05 PM
Witherspoon Charles	VP & Treasurer	Oct 29 '24	Sale	310.40	703	218,211	1,253	Oct 31 12:05 PM
Abraham Silji	SVP, Chief Technology Officer	Oct 29 '24	Option Exercise	0.00	458	0	3,318	Oct 31 11:50 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

West Pharmaceutical Services, Inc

Upgrade your FINVIZ experience